文献速递临床试验与 GCP流行病学与生物统计

在西藏通过电子监测器和应用程序改善结核患者治疗依从性对比常规治疗的随机对照试验方案

Protocol for a randomised controlled trial to evaluate the effectiveness of improving tuberculosis patients' treatment adherence via electronic monitors and an app versus usual care in Tibet.
PubMed 文献 · Trials · 2019-05-16

该研究为在西藏日喀则开展的多中心、平行组、个体随机、优效性试验,纳入新发肺结核门诊患者(年龄≥15岁),按1:1随机分为干预组和对照组。干预组使用带自动语音提醒的电子监测器并经云连接共享服药数据,对照组电子监测器关闭提醒功能且不连接应用程序。主要结局为治疗期间每月评估的不依从率(一个月内漏服≥20%剂量)。

要点

  • 干预组使用带语音提醒的电子监测器并通过云连接共享服药数据,对照组监测器关闭提醒且不连接应用程序。
  • 主要结局为治疗期间每月评估的不依从率,不依从定义为一个月内漏服≥20%剂量。
  • 所有患者均按世界卫生组织标准6个月结核治疗方案和中国国家结核病规划指南治疗。

核心结论

  • 该研究旨在了解干预措施的可行性、有效性、成本效益和长期影响,为未来在中国偏远地区和其他中低收入国家扩大应用提供信息。

研究设计与样本

  • 多中心、平行组、个体随机、优效性试验,采用盲法结局评估和非盲法治疗。
  • 从西藏日喀则纳入新发肺结核门诊患者(年龄≥15岁且无沟通障碍),在诊断时按1:1比例随机分配至干预组或对照组。
  • 所有患者均按世界卫生组织标准6个月结核治疗方案和中国国家结核病规划指南进行治疗。
  • 干预组患者通过带自动语音提醒的电子监测器给药,记录服药依从性数据并通过云连接与卫生工作人员共享;若依从性有问题,鼓励干预组患者接受基于智能手机的视频观察治疗。
  • 对照组患者通过电子监测器给药以收集服药依从性历史,但提醒功能停用且不连接应用程序。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Treatment non-adherence is a serious challenge to effective tuberculosis (TB) control in Tibet. In this study we will pilot and evaluate the effectiveness of using new electronic monitors (e-monitors) and a smartphone app to improve treatment adherence among new pulmonary TB patients in Tibet. METHODS: We will use a multicentre, parallel-group, individually randomised controlled, superiority trial with blinded outcome evaluation and unblinded treatment. We will randomise new pulmonary TB outpatients (aged ≥ 15 years old and free from communication impairment) from Shigatse, Tibet to either the intervention or control arm in a 1:1 ratio at the time of their diagnosis. All patients will be treated according to the World Health Organisation standard 6-month TB treatment regimen and the China National TB programme guidelines. Intervention arm patients will be given their medication via e-monitors that have automatic voice reminders, and record medication adherence data and share it with health staff via Cloud connection. Intervention patients will also be encouraged to receive smartphone-based video-observed treatment if their adherence is problematic. Control arm patients will receive their medication in e-monitors that will collect medication adherence history, but will have their reminder function deactivated and are not linked to the app. The primary outcome is the rate of poor adherence, measured monthly during treatment as a binary indicator where poor adherence means missing ≥ 20% of doses in a month. We will conduct a qualitative process evaluation to explore operational questions regarding acceptability, cultural appropriateness and burden of technology use, as well as a cost-effectiveness analysis and an analysis of the long-term effects of the intervention on TB control. DISCUSSION: Our study is one of the first trials to evaluate the use of e-monitors and smartphone apps for customised treatment support in low- and middle-income countries (LMICs). All intervention activities are designed to be embedded into routine TB care with strong local ownership. Through the trial we intend to understand the feasibility of our intervention, its effectiveness, its cost-effectiveness and its long-term impacts to inform future scale-up in remote areas of China and other LMICs. TRIAL REGISTRATION: Current Controlled Trials, ID: ISRCTN52132803 . Registered on 9 November 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Wei X, Hicks JP, Pasang P, et al. Protocol for a randomised controlled trial to evaluate the effectiveness of improving tuberculosis patients' treatment adherence via electronic monitors and an app versus usual care in Tibet. Trials. 2019. PMID: 31097023. doi:10.1186/s13063-019-3364-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。